ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.49
0.81%
US Tech 100
19,476.00
1.10%
S&P 500
5,751.07
0.90%
US Dollar vs CAD
1.35813
0.01%
Bitcoin
63,914.15
1.75%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Emergent Biosolutions Inc (EBS) Share Price

Emergent Biosolutions Inc

Emergent Biosolutions Inc (EBS)

NYSE
9.35
0.41
(4.59%)
Closed October 06 3:00PM
Delayed by 15 minutes
9.21
-0.14
(-1.50%)
After Hours: 6:57PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
9.21
Bid
-
Ask
-
Volume
1,635,131
8.86 Day's Range 9.57
1.42 52 Week Range 15.10
Market Cap
487.27M
Previous Close
8.94
Open
9.04
Last Trade
23
@
9.2101
Last Trade Time
Financial Volume
US$ 15,090,179
VWAP
9.2287
Average Volume (3m)
3,123,291
Shares Outstanding
52,906,624
Dividend Yield
-
PE Ratio
-0.65
Earnings Per Share (EPS)
-14.37
Revenue
1.05B
Net Profit
-760.5M

About Emergent Biosolutions Inc

Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based... Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.emergentbiosolutions.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Emergent Biosolutions Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker EBS. The last closing price for Emergent Biosolutions was US$8.94. Over the last year, Emergent Biosolutions shares have traded in a share price range of US$ 1.42 to US$ 15.10.

Emergent Biosolutions currently has 52,906,624 shares outstanding. The market capitalization of Emergent Biosolutions is US$472.99 million. Emergent Biosolutions has a price to earnings ratio (PE ratio) of -0.65.

Ask ADVFN Intelligence (AI)

Emergent Biosolutions (EBS) Options Flow Summary

EBS Options Flow

Overall Flow

Bullish

Net Premium

53k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

EBS Latest News

More News

Form 8-K - Current report

October 04 2024
Edgar (US Regulatory)

Form 8-K - Current report

October 02 2024
Edgar (US Regulatory)

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility

GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an...

October 02 2024
GlobeNewswire Inc.

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

GAITHERSBURG, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) today announced that two contract options have been secured to procure additional...

September 26 2024
GlobeNewswire Inc.

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

GAITHERSBURG, Md., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured approximately $400 million in orders in 2024 and 2025 associated with...

September 25 2024
GlobeNewswire Inc.

Form 8-K - Current report

September 17 2024
Edgar (US Regulatory)

Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation

GAITHERSBURG, Md., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent” or the “Company”) today announced that it has entered into an agreement to resolve the...

September 13 2024
GlobeNewswire Inc.

Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

GAITHERSBURG, Md., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a contract modification executing an option period by...

September 12 2024
GlobeNewswire Inc.

Form 8-K - Current report

September 03 2024
Edgar (US Regulatory)

Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile

GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) --  Emergent BioSolutions Inc. (NYSE: EBS) today announced the closing of a new credit facility agreement with Oak Hill Advisors for a term...

September 03 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.8825.64802182817.339.357.0323068848.35081551CS
41.6221.34387351787.599.355.6921867317.24259112CS
12-0.82-8.1754735792610.0315.15.2531232919.34809099CS
266.91300.4347826092.315.11.820139402096.1566005CS
526.19204.9668874173.0215.11.4230961704.83103797CS
156-45.37-83.125687064954.5855.211.42180680210.46011651CS
260-44.82-82.953914491954.03137.611.42132074323.08939264CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OCFTOneConnect Financial Technology Co Ltd
US$ 3.02
(25.83%)
476.33k
OKLOOklo Inc
US$ 11.17
(18.70%)
7.25M
SRFMSurf Air Mobility Inc
US$ 1.9401
(17.58%)
433.66k
AMPXAmprius Technologies Inc
US$ 1.23
(16.04%)
7M
JKSJinkosolar Holdings Co Ltd
US$ 29.93
(14.72%)
2.98M
SAVESpirit Airlines Inc
US$ 1.69
(-24.55%)
36.9M
XINXinyuan Real Estate Co Ltd
US$ 4.331
(-24.42%)
655.94k
HKDAmtd Digital Inc
US$ 4.355
(-16.57%)
3.93M
STEMStem Inc
US$ 0.4158
(-13.38%)
8.48M
ZIMZIM Integrated Shipping Services Ltd
US$ 18.95
(-12.55%)
21.49M
NIONIO Inc
US$ 6.775
(1.12%)
92.2M
PLTRPalantir Technologies Inc
US$ 40.01
(1.96%)
62.66M
FFord Motor Company
US$ 10.57
(1.15%)
45.97M
ABEVAmbev SA
US$ 2.46
(-0.81%)
43.09M
SAVESpirit Airlines Inc
US$ 1.69
(-24.55%)
36.9M

EBS Discussion

View Posts
eyeownu eyeownu 4 days ago
easy money
👍️0
eyeownu eyeownu 4 days ago
$EBS bonds already higher than a few weeks ago (share price here was at 15$), but shorty morons still believe that we should be lower.

The lesson will be painful. https://stocktwits.com/WinstonSmith33/message/587766900
👍️0
eyeownu eyeownu 5 days ago
$EBS Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility https://markets.businessinsider.com/news/stocks/emergent-biosolutions-announces-closing-of-100-million-asset-backed-loan-facility-1033814631
👍️0
Stockexpertpro Stockexpertpro 6 days ago
EBS California to Require narcan be at all businesses in the state singed into law mins ago This could go nationwide
👍️0
eyeownu eyeownu 1 week ago
$EBS Newsom signs bill pushing for Narcan in workplace first aid kits https://www.latimes.com/california/story/2024-09-28/california-naloxone-first-aid-kits
👍️0
eyeownu eyeownu 1 week ago
$EBS amazon to stock narcan at workplace https://www.wsj.com/business/amazon-to-stock-opioid-overdose-reversal-drug-narcan-at-its-warehouses-2ea8d831
👍️0
eyeownu eyeownu 1 week ago
$EBS https://newstalkkgvo.com/montana-narcan-kits-public/ Missoula, MT (KGVO-AM News) - Montana Attorney General Austin Knudsen appeared on Monday’s Talk Back show to continue his emphasis on the fight against fentanyl coming into Montana. Knudsen began by reminding listeners about just how deadly fentanyl can be.

“Narcan is a counter agent to fentanyl,” began Knudsen. “Fentanyl is a synthetic opioid. That opioid molecule, once you ingest it, attaches to your brain stem and it puts you into a deep, deep sleep by knocking you out. For a lot of people, it makes you stop breathing and you die.”



Read More: Montana AG Wants Narcan First Aid Kits in Public Spaces | https://newstalkkgvo.com/montana-narcan-kits-public/?utm_source=tsmclip&utm_medium=referral
👍️0
eyeownu eyeownu 1 week ago
my $EBS bags are heavy
👍️0
Biggiee Biggiee 2 weeks ago
Looks like when EBS refinanced their debt, they became the usual “sell the news” kind of stock. Too bad, it had a good honest run from $2-$15. Biz as usual now
👍️0
Roadtojourney Roadtojourney 2 weeks ago
What a waste, liars $400 million order to sell the shares seems like???
👍️0
Monksdream Monksdream 4 weeks ago
EBS chart
👍️0
eyeownu eyeownu 1 month ago
added more this will be in double digits in no time. alllllllllllll aboard.
👍️0
allenc allenc 1 month ago
Expect we see a contract for the vaccine soon. $200M in debt reduction, anticipating increase sales of Narcan, this should be a booming Q4 IMO.
👍️ 1
Biggiee Biggiee 1 month ago
https://www.unicef.org/press-releases/unicef-issues-emergency-tender-secure-mpox-vaccines-crisis-hit-countries
👍️0
eyeownu eyeownu 1 month ago
bought 2500 shares today
👍️0
Biggiee Biggiee 1 month ago
Nasty bull trap with that FDA news ah yesterday, but should snap back to double digits when the dark overlords are done playing
👍️0
81vette 81vette 1 month ago
Tutes own 58%,short 3.5m(covering coming)shares to short dropping now,fee rising and rebate dropping,tutes want their shares back before it runs up,patience required on my part isn’t easy lol.
👍️0
Biggiee Biggiee 1 month ago
Loading up now, see you next week!
GLTA
👍️0
Roadtojourney Roadtojourney 1 month ago
What a pos seems like approval was already priced in?? Sell on news??
👍️0
Biggiee Biggiee 1 month ago
FDA approval for MPOX
👍️0
Biggiee Biggiee 1 month ago
$EBS Rodman & Renshaw initiated coverage of Emergent Biosolutions (NYSE: EBS) with a price target of $16.
👍️0
LEFTY1182 LEFTY1182 2 months ago
Soon enough people will catch on with the monkey pox coming! $200+ coming here imo
👍️0
Biggiee Biggiee 2 months ago
Why do I bother messaging this board? Talking to myself! Goodnight!
👍️0
Biggiee Biggiee 2 months ago
It’s go time once more!
👍️0
Biggiee Biggiee 2 months ago
Selling my 9’s here @10.10. Quick flip, I think she goes lower.
GLTA
👍️0
Biggiee Biggiee 2 months ago
Sold yesterday, looking for a pullback now to $9’s. Media hasn’t latched on to the crisis fear just yet, we shall see
$EBS
👍️0
81vette 81vette 2 months ago
Shares to short dropping,getting excited as word is spreading faster than the virus lol
👍️0
81vette 81vette 2 months ago
3.6m short,could squeeze big after hrs
👍️0
Biggiee Biggiee 2 months ago
The coming news cycle of “fear the mpox” will do more than just pop. I see a sustained rising trend from here on out. Start looking at the weekly and monthly charts instead of the daily.
$EBS
👍️0
EnchantedTitan62 EnchantedTitan62 2 months ago
If they get FDA approval which they are now seeking, it will surely pop again.
👍️0
Biggiee Biggiee 2 months ago
It’s go time again, monkey biz
👍️0
Biggiee Biggiee 2 months ago
Yikes! Smoldering crater
👍️0
Biggiee Biggiee 2 months ago
Todays the day! Place your bets for AH
GLtA
👍️0
Biggiee Biggiee 2 months ago
Tree shake! Earnings coming on Aug 6 AH
One to watch $EBS
👍️0
Biggiee Biggiee 2 months ago
Feels like it could be a buy out. Market cap isn’t even a billy, and we are talking about NARCAN! Any guesses above these prices seems like a good bet
👍️0
Sirpeter Sirpeter 2 months ago
How high do you see this going
👍️0
Biggiee Biggiee 2 months ago
F’in beast! $14!
👍️0
Biggiee Biggiee 2 months ago
$13 hit. Such a beast!
👍️0
Biggiee Biggiee 2 months ago
Jumped back in $12.01, I think it’s time to challenge $13
👍️0
Biggiee Biggiee 2 months ago
Looking for the right time to get back in here. $EBS
👍️0
EnchantedTitan62 EnchantedTitan62 3 months ago
Thanks, left some on the table too. I see youve been here for awhile so I'm ' following' ya for any good plays. My picks tend to be long term . Good day sir.
👍️0
Biggiee Biggiee 3 months ago
Nice! Cheers!
👍️0
EnchantedTitan62 EnchantedTitan62 3 months ago
Sold 175 @ 12.05 for $7 gain/share. Not enough to buy a beach house in Cape Cod, but I can buy a plane ticket ! Ha.
👍️0
Biggiee Biggiee 3 months ago
Out 12.20, will jump back in once they finish shaking the tree. Thanks!
👍️0
Biggiee Biggiee 3 months ago
lol, life goes on
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
EBS...TOP IS IN
👍️0
EnchantedTitan62 EnchantedTitan62 3 months ago
Taking a break from chopping wood for the winter. Looks like another day IN THE GREEN. 💲
👍️0
Biggiee Biggiee 3 months ago
Makes sense. The big shorts are leaving the small fries to burn?
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
THE SHORT YESTERDAY WAS ONLY 350 000 AND SHORT COVERING WAS 850 000....IT WAS INTENDED TO LOWER PPS TO COVER
👍️0
Biggiee Biggiee 3 months ago
Short attack failed, see you on the moon
$EBS
👍️0

Your Recent History

NYSE
EBS
Emergent Biosolutions
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved